Role of the Antineoplastic Drug Bleomycin Based on Toxicogenomic-DNA Damage Inducing (TGx-DDI) Genomic Biomarkers Data: A Meta-analysis

Overview

Journal Pak J Med Sci

Specialty General Medicine

Date 2023 Mar 23

PMID 36950431

Authors

Peter Natesan Pushparaj

Mahmood Rasool

Muhammad Imran Naseer

Kalamegam Gauthaman

Affiliations

Soon will be listed here.

Abstract

Objectives: Accurately identifying the cellular, biomolecular, and toxicological functions of anticancer drugs help to decipher the potential risk of genotoxicity and other side effects. Here, we examined bleomycin for cellular, molecular and toxicological mechanisms using next-generation knowledge discovery (NGKD) tools.

Methods: This study was conducted at the Faculty of Applied Medical Sciences, King Abdulaziz University (KAU), Jeddah, Saudi Arabia in October 2022. We first analyzed the raw Toxicogenomic and DNA damage-inducing (TGx-DDI) gene expression data from Gene Expression Omnibus (GEO) (GSE196373) of TK6 cells treated with 10 µM bleomycin and TK6 cells treated with DMSO for four hours using the GEO2R tool based on the Linear Models for Microarray Analysis (limma) R packages to derive the differentially expressed genes (DEGs). Then, iPathwayGuide was used to determine differentially regulated signaling pathways, biological processes, cellular, molecular functions and upstream regulators (genes and miRNAs).

Results: Bleomycin differently regulates the p53 pathway, transcriptional dysregulation in cancer, FOXO pathway, viral carcinogenesis, and cancer pathways. The biological processes such as p53 class mediator signaling, intrinsic apoptotic signaling, DNA damage response, and DNA damage-induced intrinsic apoptotic signaling and molecular functions like ubiquitin protein transferase and p53 binding were differentially regulated by bleomycin. iPathwayGuide analysis showed that the p53 and its regulatory gene and microRNA networks induced by bleomycin.

Conclusion: Analysis of TGx-DDI data of bleomycin using NGKD tools provided information about toxicogenomics and other mechanisms. Integration of all "omics" based approaches is crucial for the development of translatable biomarkers for evaluating anticancer drugs for safety and efficacy.

Citing Articles

Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials.

Chatterjee A, Khan R, Mukherjee T, Sahoo P, Tiwari L, Singh B Arch Microbiol. 2024; 206(11):449.

PMID: 39472338 DOI: 10.1007/s00203-024-04179-x.

Exploration of potential molecular mechanisms and genotoxicity of anti-cancer drugs using next generation knowledge discovery methods.

Pushparaj P, Rasool M, Naseer M, Gauthaman K Pak J Med Sci. 2023; 39(4):988-993.

PMID: 37492288 PMC: 10364265. DOI: 10.12669/pjms.39.4.7427.

References

Draghici S, Khatri P, Tarca A, Amin K, Done A, Voichita C . A systems biology approach for pathway level analysis. Genome Res. 2007; 17(10):1537-45. PMC: 1987343. DOI: 10.1101/gr.6202607. View

Engeland K . Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022; 29(5):946-960. PMC: 9090780. DOI: 10.1038/s41418-022-00988-z. View

Miyake Z, Takekawa M, Ge Q, Saito H . Activation of MTK1/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain. Mol Cell Biol. 2007; 27(7):2765-76. PMC: 1899887. DOI: 10.1128/MCB.01435-06. View

Chen X, Xu Y, Jiang L, Tan Q . miRNA-218-5p increases cell sensitivity by inhibiting PRKDC activity in radiation-resistant lung carcinoma cells. Thorac Cancer. 2021; 12(10):1549-1557. PMC: 8107034. DOI: 10.1111/1759-7714.13939. View

Pushparaj P, Kalamegam G, Sait K, Rasool M . Decoding the Role of Astrocytes in the Entorhinal Cortex in Alzheimer's Disease Using High-Dimensional Single-Nucleus RNA Sequencing Data and Next-Generation Knowledge Discovery Methodologies: Focus on Drugs and Natural Product Remedies for Dementia. Front Pharmacol. 2022; 12:720170. PMC: 8918735. DOI: 10.3389/fphar.2021.720170. View

Ashburner M, Lewis S . On ontologies for biologists: the Gene Ontology--untangling the web. Novartis Found Symp. 2003; 247:66-80; discussion 80-3, 84-90, 244-52. View

Xu Y, He Q, Lu Y, Tao F, Zhao L, Ou R . MicroRNA-218-5p inhibits cell growth and metastasis in cervical cancer via /NF-κB signaling pathway. Cancer Cell Int. 2018; 18:198. PMC: 6278036. DOI: 10.1186/s12935-018-0673-1. View

Zraik I, Hess-Busch Y . [Management of chemotherapy side effects and their long-term sequelae]. Urologe A. 2021; 60(7):862-871. DOI: 10.1007/s00120-021-01569-7. View

Amundson S, Do K, Vinikoor L, Koch-Paiz C, Bittner M, Trent J . Stress-specific signatures: expression profiling of p53 wild-type and -null human cells. Oncogene. 2005; 24(28):4572-9. DOI: 10.1038/sj.onc.1208653. View

10.

Bryce S, Bemis J, Mereness J, Spellman R, Moss J, Dickinson D . Interpreting in vitro micronucleus positive results: simple biomarker matrix discriminates clastogens, aneugens, and misleading positive agents. Environ Mol Mutagen. 2014; 55(7):542-55. DOI: 10.1002/em.21868. View

11.

Harris S, Levine A . The p53 pathway: positive and negative feedback loops. Oncogene. 2005; 24(17):2899-908. DOI: 10.1038/sj.onc.1208615. View

12.

Agarwal V, Bell G, Nam J, Bartel D . Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015; 4. PMC: 4532895. DOI: 10.7554/eLife.05005. View

13.

Xie D, Li S, Wu T, Wang X, Fang L . MiR-181c suppresses triple-negative breast cancer tumorigenesis by targeting MAP4K4. Pathol Res Pract. 2022; 230:153763. DOI: 10.1016/j.prp.2022.153763. View

14.

Skopek T, Liber H, Penman B, Thilly W . Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: possibility for a rapid human cell mutation assay. Biochem Biophys Res Commun. 1978; 84(2):411-6. DOI: 10.1016/0006-291x(78)90185-7. View

15.

Draghici S, Khatri P, Martins R, Ostermeier G, Krawetz S . Global functional profiling of gene expression. Genomics. 2003; 81(2):98-104. DOI: 10.1016/s0888-7543(02)00021-6. View

16.

Li H, Chen R, Hyduke D, Williams A, Frotschl R, Ellinger-Ziegelbauer H . Development and validation of a high-throughput transcriptomic biomarker to address 21st century genetic toxicology needs. Proc Natl Acad Sci U S A. 2017; 114(51):E10881-E10889. PMC: 5754797. DOI: 10.1073/pnas.1714109114. View

17.

Huang H, Tindall D . Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Biochim Biophys Acta. 2011; 1813(11):1961-4. PMC: 3110514. DOI: 10.1016/j.bbamcr.2011.01.007. View

18.

Buick J, Rowan-Carroll A, Gagne R, Williams A, Chen R, Li H . Integrated Genotoxicity Testing of three anti-infective drugs using the TGx-DDI transcriptomic biomarker and high-throughput CometChip assay in TK6 cells. Front Toxicol. 2022; 4:991590. PMC: 9540394. DOI: 10.3389/ftox.2022.991590. View

19.

Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View

20.

Szklarczyk D, Morris J, Cook H, Kuhn M, Wyder S, Simonovic M . The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2016; 45(D1):D362-D368. PMC: 5210637. DOI: 10.1093/nar/gkw937. View